CIBC Asset Management
CATX icon

CIBC Asset Management’s Perspective Therapeutics CATX Stock Holding History

CIBC Asset Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,917
Closed -$87.2K – 1445
2026
Q1 		$87.2K Hold
20,917
– – ﹤0.01% 1322
2025
Q4 		$57.5K Hold
20,917
– – ﹤0.01% 1337
2025
Q3 		$71.7K Hold
20,917
– – ﹤0.01% 1216
2025
Q2 		$72K Hold
20,917
– – ﹤0.01% 1199
2025
Q1 		$44.6K Buy
20,917
+401
+2% +$1.2K ﹤0.01% 1164
2024
Q4 		$65.4K Buy
20,516
+1,101
+6% +$8.99K ﹤0.01% 1196
2024
Q3 		$259K Buy
+19,415
New +$258K ﹤0.01% 943

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

CIBC Asset Management's CATX Position: Q2 2026 in Review

CIBC Asset Management sold out of Perspective Therapeutics (CATX) in Q2 2026, closing a stake of 20,917 shares — an estimated $87.2K sold.

CIBC Asset Management first reported a position in CATX in Q3 2024 and held it in 7 quarters. The position peaked at $259K in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • CIBC Asset Management reported no remaining Perspective Therapeutics position as of Q2 2026 after selling out during the quarter.
  • CIBC Asset Management sold 20,917 Perspective Therapeutics shares in Q2 2026, an estimated $87.2K.
  • CIBC Asset Management first reported a position in Perspective Therapeutics in Q3 2024 and held it in 7 quarters.
  • CIBC Asset Management's Perspective Therapeutics position peaked at $259K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.